1. Introduction {#S6}
===============

Cardiovascular disease (CVD) is an established macrovascular complication of type 2 diabetes (T2D), and individuals with T2D are known to be at an increased risk for early onset of CVD. Adults with any type of diabetes have death rates from CVD 1.7 times higher than adults who do not have diabetes ([@R1]). In adults aged 65 years and older with diabetes-related causes of death, 68% of death certificates also cite heart disease and 16% also cite stroke as causes of death ([@R2]). These problems are magnified in the population by the increasing incidence of T2D ([@R3]). Additionally, it is well-known that atherosclerosis emerges during childhood ([@R4]--[@R5]). Therefore, the estimated 5,100 youth who are diagnosed with T2D each year in the United States may be at a higher risk for cardiovascular morbidity and mortality because of the early onset and longer duration of T2D as they enter adulthood ([@R6]). The SEARCH for Diabetes in Youth Study (SEARCH) has shown that youth with T2D have more arterial stiffness than youth with type 1 diabetes (T1D), while the TODAY study has shown that over a 3 year period, the number of youth with T2D meeting recommended thresholds for treatment with lipid-lowering medication treatment tripled ([@R7]--[@R8]).

Familial clustering of cardiovascular disease risk factors such as T2D, hypertension, hypercholesterolemia, and hyperalbuminuria is well-known. Certainly, shared lifestyles are involved in the pathophysiology of the development of these disorders; however, family and twin studies also suggest underlying genetic and epigenetic influences ([@R9]--[@R15]). Additionally, CVD risk factors have been shown to differ by ethnicity ([@R16]). Considering the interplay of genetic background and epigenetic and lifestyle influences, it is plausible that the relationship between family history of diabetes and the risk for CVD in offspring may differ for individuals of varying racial or ethnic backgrounds.

Therefore, the goal of this study was to explore the association between parental diabetes and the CVD risk profiles of youth with T2D enrolled in the SEARCH study. The secondary goal of this study was to examine whether the association between parental history and CVD risk profile also differed by race or ethnicity. We hypothesized that unhealthier CVD risk factors \[as assessed by higher levels of HbA1c, higher blood pressure (BP), higher fasting total cholesterol (TC), higher fasting low density lipoprotein (LDL), higher fasting triglycerides (TG), lower fasting high density lipoprotein (HDL), higher apolipoprotein B (apoB), and higher urine albumin to creatinine ratio (ACR)\] would be most likely present in the offspring of two parents with diabetes and the most favorable profile would be seen in those without a parental history of diabetes. Among youth with T2D with at least one parent with diabetes, we hypothesized that those with a mother with diabetes would have a more adverse CVD risk profile than those with a father with diabetes due to the additional contribution of possible intrauterine exposure.

2. Subjects, Materials, and Methods {#S7}
===================================

Data for these analyses were collected as part of the SEARCH study protocol. A detailed description of the SEARCH study methods has been published elsewhere([@R17]). Briefly, SEARCH has been conducting population-based case ascertainment of youth \< 20 years old with prevalent diabetes in 2001 and 2009 and newly diagnosed (incident) diabetes starting in 2002 and continuing through the present. SEARCH recruited participants from four geographically defined populations in Ohio, Colorado, South Carolina and Washington, as well as from Indian Health Service beneficiary roles of several American Indian populations, and among enrollees in a managed health care plan in California. Participants were invited to participate in a research visit, during which fasting blood samples were obtained if metabolically stable (defined as no episode of diabetic ketoacidosis during the previous month), physical measurements were taken, and questionnaires were administered. The study was reviewed and approved by the local Institutional Review Board(s) that had jurisdiction over the local study population and all participants provided informed consent and/or assent.

2.1. Measurements {#S8}
-----------------

Study visits occurred after an eight hour overnight fast. Participants did not take diabetes medications the morning of the visit. Participants on long-acting insulin took it the evening before the visit and then it was withheld. A brief physical examination was conducted including measurement of BP, weight, and height using standardized procedures. Body mass index was calculated (BMI \[kg/m^2^\]), and age- and sex-specific BMI z-scores were calculated using growth charts with a SAS program available from the Centers for Disease Control and Prevention([@R18]). Waist circumference was measured using NHANES III protocol([@R19]). Waist z-scores were calculated by age and gender from CDC growth reference year 2000. Race and ethnicity were self-reported using 2000 United States Census questions([@R20]) and classified as Hispanic, non- Hispanic White(NHW), non-Hispanic Black(NHB), American Indian(AI), and Asian/Pacific Islander(API). For these analyses, race or ethnicity was categorized as NHB, Hispanic, NHW, and combined API/AI. API and AI were combined to create a category of comparable size to the other categories and also of sufficient size for analysis. Family history of diabetes was collected by questionnaire; however, information on type of parental diabetes was not collected. History of parental diabetes at any time point (regardless of timing with offspring's birth or diagnosis) was classified as a positive parental history in these analyses.

Fasting blood samples were used to analyze diabetes autoantibodies (DAA), HbA1c and lipids (TC, TG, HDL, LDL, and apoB). Spot urine samples were used to measure ACR. Assays were performed at the Northwest Lipid Metabolism and Diabetes Research Laboratories, University of Washington. Glutamic acid decarboxylase-65 (GAD65) and insulinoma-associated-2 (IA-2A) autoantibodies were analyzed using a standardized protocol and a common serum calibrator developed by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) sponsored standardization group([@R21]). The cutoff values for positivity were 33 NIDDKU/ml for GAD65 and 5 NIDDKU/ml for IA-2A. HbA1c(%) was measured in whole blood with an automated nonporous ion-exchange high-performance liquid chromatography system(model G-7; Tosoh Bioscience, Montgomeryville, Pennsylvania).

2.2. Study Participants {#S9}
-----------------------

Inclusion criteria for this report include all youth aged \< 20 years whose diabetes was prevalent in 2001 or newly diagnosed in 2002--2005, with T2D as diagnosed by their health care provider and who had a SEARCH study visit (n=581). From the 581 individuals, we hierarchically excluded those with positive DAA (n=42), time from diagnosis to initial study visit was less than 3 months to allow for some stabilization of glycemic control which could otherwise negatively impact outcome measures (n=26), history of steroid use or diagnosis of other medical conditions frequently treated with steroids (n=9), missing information for race or ethnicity (n=4), missing information on all outcomes of interest (n=45), and those for whom we were unable to determine that at least 1 parent had diabetes or both parents did not have diabetes (n=73). For the four category exposure analysis, we excluded an additional 20 individuals for whom diabetes status could not be determined for both parents.

2.3. Statistical Analysis {#S10}
-------------------------

Participant characteristics were described using means(SD) or proportions(%). Comparisons across parental diabetes groups were examined using chi square or Fisher's exact test, as well as simple and multivariable logistic regression models (categorical outcomes), or simple and multivariable linear regression models (continuous outcomes). Natural log transformation was applied to the triglyceride variable before analysis due to skewed distribution.

Parental diabetes exposure groups were divided both into 2 categories \[parental history of diabetes in either or both parents (parental DM) and no parental history of diabetes(no parental DM)\] and 4 categories \[both parents with history of diabetes(both parents DM), maternal history of diabetes only(maternal DM), paternal history of diabetes only(paternal DM), and no parental history of diabetes(no parental DM)\]. The 2 category exposure definition was examined overall and stratified by the 4 race or ethnicity groups (NHB, Hispanic, NHW, and API/AI), however the 4 category exposure definition was not stratified by race or ethnicity because of sample size limitations.

Modeling was conducted using sequential models with groups of covariates added to subsequent models culminating in the maximally adjusted model. Model covariates included: gender, clinic, highest parental education, smoking status, physical activity level, BMI z-score, waist z-score, time since diagnosis, age at diagnosis, insulin use, hypertensive medication use (blood pressure and ACR outcomes only), and lipid medication use (lipid outcomes only). In these descriptive analyses, we chose not to adjust for multiple comparisons, although by testing several variables in the present study, we may have increased the likelihood of uncovering spurious associations that would need verification in other populations.

All statistical comparisons were conducted using SAS version 9.3 (SAS Institute, Cary, NC, USA). Results were considered significant if p \< 0.05.

3. Results {#S11}
==========

Overall, 382 participants were included in the two category analysis of parental diabetes, and 362 participants were included in the four category analysis of parental diabetes ([Table 1](#T1){ref-type="table"}). Participants in the two category analysis were diagnosed with T2D at a mean age of 13.8 ± 2.5 years, had been diagnosed for a mean of 26.6 ± 22.2 months at the time of their study visit, were predominantly of non-white racial or ethnic groups (38.2% NHB, 23.0% Hispanic, 19.6% API/AI), and had a mean BMI z-score at SEARCH visit of 2.1 ± 0.7. There were no differences between categories of parental diabetes for these participant characteristics in the two-category analysis. Participant characteristics were similar for those participants included in the four-category analysis with the exception of duration of diabetes at time of SEARCH visit. The duration of T2D in the four-category analysis varied significantly from 23.5 ± 20.8 months for those with no parental diabetes to 34.8 ± 25.5 for those with both parents having a diagnosis of diabetes (p=0.009).

Unadjusted comparison of CVD risk profile outcomes by the two categories of parental history of diabetes revealed that participants with a parental history of diabetes overall had significantly higher HbA1c \[8.1% ± 2.5 v. 7.4 ± 2.6 (65.4mmol/mol ± 27.3 v. 57.2 ± 28.2), p=0.008\], higher DBP (74.3 mmHg ± 10.4 v. 71.7 ± 10.8, p=0.025), and higher percentage with elevated ACR \[25.9% v. 15.5, OR95% CI) 1.9(1.02, 3.52), p=0.043\] than those in the no parental diabetes group ([Table 1](#T1){ref-type="table"}). However, none of these relationships except elevated ACR were significant after initial adjustments for confounders ([Table 2](#T2){ref-type="table"}). In the models stratified by race or ethnicity, significantly higher HbA1c, DBP, and lnTG remained after adjustment in the NHW group with parental diabetes compared to the NHW group without parental diabetes \[HbA1c 8.0% ± 0.4 v. 6.8 ± 0.4 (63.9 mmol/mol ± 4.2 v. 51.1 ± 4.8), p=0.015; DBP 76.9 mmHg ± 4.4 v. 67.7 ±4.5, p=0.014; and lnTG 5.3 ± 0.3 v. 4.7 ±0.3, p=0.008\]. However, none of the other race or ethnic group-related models demonstrated significant associations between CVD risk factors and parental history of diabetes (data not shown). Interaction of race or ethnicity groups with the two-category exposure on CVD risk factors was only statistically significant for DBP (p=0.048).

Unadjusted four category comparison of CVD risk profile outcomes ([Table 1](#T1){ref-type="table"}) revealed significant differences in HbA1c levels (p=0.047) such that the highest HbA1c was in the group with both parents with diabetes (8.5% ± 2.5, 68.9 mmol/mol ± 27.7) followed by those with a father with diabetes (8.1% ± 2.6, 65.0 mmol/mol ± 28.5), a mother with diabetes (8.0% ± 2.5, 63.9 mmol/mol ± 27.3), and no parent with diabetes (7.4% ± 2.6, 57.2 mmol/mol ± 28.2) \[p=0.01 for both parents v. no parent with diabetes\]. Differences were no longer significant when controlled for demographic and health behavior variables (data not shown).

4. Discussion {#S12}
=============

Our unadjusted findings suggest that among the total sample of youth with T2D, a parental history of diabetes is associated with higher HbA1c, higher DBP, and higher odds of elevated ACR, and the association with ACR remained after adjustment. Among the NHW youth, all models showed HbA1c and DBP to be significantly associated with parental diabetes, and lnTG emerged as significantly associated. No significant associations were observed among the other three race or ethnic groups studied.

Our study furthers previous work in SEARCH examining the influence of parental diabetes on characteristics of youth with T2D, including the finding that youth with T2D who are exposed to diabetes in utero are diagnosed at a younger age and that history of maternal diabetes and obesity during pregnancy accounts for 47.2% of T2D in youth ([@R22]--[@R23]). SEARCH has also previously shown that children with T2D who have a family history of diabetes onset after age 25 had more atherogenic lipid profiles, higher blood pressures, larger waist circumferences, and higher BMI z-scores ([@R24]). However, in this earlier SEARCH phase, siblings and grandparents were included along with the parents and not differentiated from the parents in the analysis.

Previous studies report from various populations that both support and contradict our findings. The Bogalusa Heart Study showed that young adults without diabetes who are offspring of parents with diabetes are more likely to be hypertensive and have higher TG levels, lower HDL, and higher LDL levels, and longitudinal changes in risk markers did not differ by race ([@R25]). Altinli et al. reported increased SBP in offspring of parents with diabetes but no difference in DBP or lipid levels in a Turkish population ([@R26]). A systematic review and meta-analysis examining blood pressure in offspring of mothers with diabetes also found only increased SBP ([@R27]). However, several other studies from the Netherlands, Germany, India, and the United States have not found associations over time between parental history of diabetes, metabolic syndrome, or gestational diabetes with offspring lipid, blood pressure, or HbA1c measurements ([@R28]-- 31). Pima Indian adults with T2D who are offspring of mothers with T2D have been shown to have higher odds of microalbuminuria, though family history of diabetes was not shown to be associated with microalbuminuria in Swedish youth with insulindependent diabetes ([@R32], [@R10]). The finding of a larger proportion with microalbuminuria and higher DBP among offspring of parents with T2D is alarming considering that these markers independently increase the risk of mortality in people with young-onset T2D ([@R33]).

The present study did not directly compare the CVD risk profiles between race or ethnic groups, and prior studies conflict regarding whether NHW individuals are more likely to have CVD risk factors compared to individuals of other race or ethnic groups. For example, SEARCH has previously shown that hypertension disproportionately affects minority race or ethnic youth with either T1D or T2D compared to NHW youth ([@R34]), while the TODAY study has reported a higher prevalence of hypertension in NHW youth with T2D than NHB and Hispanic youth ([@R35]), and a systematic review showed NHW adults with either T1D or T2D have a higher risk for CVD complications than NHB, Hispanic Americans, and Asian Americans ([@R36]). Therefore, it is possible that the higher HbA1c, DBP, and lnTG that the present study found in the NHW group with a parental history of diabetes may compound an underlying higher risk for CVD in NHW youth with T2D.

One of the great strengths of SEARCH is that its cohort derives from a diverse racial and ethnic population. A limitation for the present study is that current SEARCH data do not differentiate between types of parental diabetes (eg, T1D, T2D, gestational, or MODY). Therefore, further associations between the particular type of parental diabetes and the offspring's CVD risk factors may be found if this information were available. An additional limitation of the present study is the use of a single random urine specimen. Intraindividual variation in ACR and orthostatic proteinuria are common in adolescents ([@R37], [@R38]). However, both situations would bias the results toward the null hypothesis due to nondifferential misclassification.

Exploring the association between parental diabetes and the CVD risk factors of offspring is difficult due to the insidious nature of T2D onset in many people. However, this work and many of the studies cited herein support a contribution of parental diabetes to adverse CVD risk factors in offspring. Given the known risk of premature CVD morbidity and mortality in adults with T2D and the rising incidence of T2D in youth, further work is required in youth with T2D to define both the contribution of parental diabetes to CVD risk in offspring and interventions to limit CVD risk.
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###### 

Characteristics of Youth with Type 2 Diabetes by Parental History of Diabetes, mean (SD) or percent

                                                Two Categories Parental Diabetes Exposure   Four Categories Parental Diabetes Exposure (n=362)[\*](#TFN1){ref-type="table-fn"}                                                                                                                                                                  
  --------------------------------------------- ------------------------------------------- ------------------------------------------------------------------------------------ -------------- -------------- ---------- ------------------------------------------- -------------- -------------- ------------------------------------------- ----------
  Male %                                        382                                         35.9                                                                                 32.7           42.2           .067       31.5                                        34.4           28.9           42.2                                        .271
                                                                                                                                                                                                                                                                                                                                                
  Race/Ethnicity                                382                                                                                                                                                                                                                                                                                             
    Non-Hispanic Black                                                                      38.2                                                                                 39.4           35.9                      35.2                                        39.8           36.5           35.9                                        
    Hispanic                                                                                23.0                                                                                 23.2           22.7           .322       24.1                                        24.2           25.0           22.7                                        .597
    Asian/Pacific Islander or American Indian                                               19.6                                                                                 20.9           17.2                      29.6                                        18.0           19.2           17.2                                        
    Non-Hispanic White                                                                      19.1                                                                                 16.5           24.2                      11.1                                        18.0           19.2           24.2                                        
                                                                                                                                                                                                                                                                                                                                                
  BMI z-score                                   370                                         2.1(0.7)                                                                             2.1(0.6)       2.0(0.9)       .438       2.0(0.6)                                    2.1(0.6)       2.0(0.7)       2.0(0.9)                                    .556
                                                                                                                                                                                                                                                                                                                                                
  Waist z-score                                 358                                         1.7(1.0)                                                                             1.7(0.9)       1.7(1.1)       .546       1.6(0.8)                                    1.7(0.9)       1.8(0.9)       1.7(1.1)                                    .635
                                                                                                                                                                                                                                                                                                                                                
  Age at Diagnosis (years)                      382                                         13.8(2.5)                                                                            13.6(2.5)      14.1(2.5)      .061       13.6(2.8)                                   13.5(2.3)      14.1(2.5)      14.1(2.5)                                   .106
                                                                                                                                                                                                                                                                                                                                                
  Duration of Type 2 Diabetes (months)          382                                         26.6(22.2)                                                                           28.2(22.8)     23.5(20.8)     .054       34.8(25.5)                                  24.6(21.2)     28.8(22.1)     23.5(20.8)                                  **.009**
                                                                                                                                                                                                                                                                                                                                                
  Highest Parent Education                      374                                                                                                                                                                                                                                                                                             
    \< High School                                                                          16.8                                                                                 17.7           15.1                      19.2                                        22.2           7.8            15.1                                        
    High School Grad                                                                        35.3                                                                                 32.7           40.5           .502       26.9                                        32.5           33.3           40.5                                        .100
    Some Coll/Assoc. Degree                                                                 31.6                                                                                 33.1           28.6                      26.9                                        33.3           41.2           28.6                                        
    Bachelor +                                                                              16.3                                                                                 16.5           15.9                      26.9                                        11.9           17.7           15.9                                        
                                                                                                                                                                                                                                                                                                                                                
  Smoking                                       372                                                                                                                                                                                                                                                                                             
    Current                                                                                 13.4                                                                                 15.4           9.6                       11.5                                        16.8           18.0           9.6                                         
    Former                                                                                  25.0                                                                                 22.7           29.6           .159       25.0                                        16.0           30.0           29.6                                        .110
    Never                                                                                   61.6                                                                                 61.9           60.8                      63.5                                        67.2           52.0           60.8                                        
                                                                                                                                                                                                                                                                                                                                                
  \% Activity \< 3 Days/Week                    372                                         47.3                                                                                 49.0           44.0           .363       40.4                                        50.4           46.0           44.0                                        .607
                                                                                                                                                                                                                                                                                                                                                
  \% 2+ Hours TV/Day                            343                                         71.8                                                                                 69.6           76.0           .198       73.1                                        68.0           70.0           76.0                                        .551
                                                                                                                                                                                                                                                                                                                                                
  \% on Hypertension Meds                       343                                         14.0                                                                                 14.9           12.2           .490       17.8                                        14.7           8.5            12.2                                        .567
                                                                                                                                                                                                                                                                                                                                                
  \% on Lipid-Lowering Meds                     343                                         3.8                                                                                  4.0            3.5            1.000      2.2                                         2.6            8.5            3.5                                         .317
                                                                                                                                                                                                                                                                                                                                                
  \% on Insulin                                 343                                         37.6                                                                                 37.7           37.4           .953       40.0                                        34.5           42.6           37.4                                        .781
                                                                                                                                                                                                                                                                                                                                                
  HbA1c %                                       361                                         7.9(2.5)                                                                             8.1(2.5)       7.4(2.6)       **.008**   8.5(2.5)[‡](#TFN3){ref-type="table-fn"}     8.0(2.5)       8.1(2.6)       7.4(2.6)[‡](#TFN3){ref-type="table-fn"}     **.047**
                                                                                                                                                                                                                                                                                                                                                
  HbA1c (mmol/mol)                              361                                         62.6(27.8)                                                                           65.4(27.3)     57.2(28.2)     **.008**   68.9(27.7)[‡](#TFN3){ref-type="table-fn"}   63.9(27.3)     65.0(28.5)     57.2(28.2)[‡](#TFN3){ref-type="table-fn"}   **.047**
                                                                                                                                                                                                                                                                                                                                                
  SBP mmHg                                      376                                         117.5(12.8)                                                                          117.6(13.0)    117.2(12.3)    .743       118.3(10.5)                                 118.3(14.0)    114.7(14.1)    117.2(12.3)                                 .381
                                                                                                                                                                                                                                                                                                                                                
  DBP mmHg                                      376                                         73.4(10.6)                                                                           74.3(10.4)     71.7(10.8)     **.025**   75.0(9.3)                                   74.1(10.6)     74.8(10.4)     71.7(10.8)                                  .111
                                                                                                                                                                                                                                                                                                                                                
  Total Cholesterol mg/dL                       324                                         178.7(41.5)                                                                          180.0(41.5)    176.3(41.7)    .440       182.5(42.4)                                 177.5(40.8)    184.0(40.7)    176.3(41.7)                                 .658
                                                                                                                                                                                                                                                                                                                                                
  HDL mg/dL                                     324                                         41.6(10.2)                                                                           41.7(10.5)     41.3(9.8)      .759       41.7(10.4)                                  42.0(11.0)     40.6(9.8)      41.3(9.8)                                   .884
                                                                                                                                                                                                                                                                                                                                                
  LDL mg/dL                                     324                                         106.7(32.6)                                                                          107.9(32.7)    104.5(32.4)    .374       108.6(32.9)                                 109.3(34.1)    109.1(30.6)    104.5(32.4)                                 .707
                                                                                                                                                                                                                                                                                                                                                
  TG mg/dL                                      324                                         169.1(172.5)                                                                         173.9(186.0)   160.1(143.6)   \-         185.1(166.3)                                142.8(100.3)   213.5(301.5)   160.1(143.6)                                \-
                                                                                                                                                                                                                                                                                                                                                
  lnTG                                          324                                         4.9(.7)                                                                              4.9(.7)        4.8(.7)        .416       5.0(.7)                                     4.8(.6)        5.0(.8)        4.8(.7)                                     .282
                                                                                                                                                                                                                                                                                                                                                
  ApoB mg/dL                                    237                                         93.6(28.3)                                                                           95.0(27.9)     90.9(29.1)     .293       94.8(26.5)                                  92.0(27.5)     106.9(26.9)    90.9(29.1)                                  .061
                                                                                                                                                                                                                                                                                                                                                
  \% with Elevated ACR                          308                                         22.4                                                                                 25.9           15.5           **.043**   32.6                                        23.3           24.4           15.5                                        .146

Overall variable sample sizes for two category exposure comparison (n=382) are similar to four category exposure comparison (n=362)

p-value for overall test of differences among all 4 groups

p= .01

###### 

Adjusted Cardiovascular Disease Risk Profiles of Youth with Type 2 Diabetes by Exposure to Parental Diabetes, Adjusted Mean (SE) or OR (95% CI)

                                            Overall   Non-Hispanic White                                                                                               
  ----------------------------------------- --------- -------------------- ------------ ----------- ---- ----------------------------------------------- ------------- -----------
  HbA1c (%)                                                                                                                                                            
  Model 1[\*](#TFN4){ref-type="table-fn"}   343       8.4(0.2)             7.8(0.3)     0.037       67   8.1(0.4)                                        6.8(0.4)      **0.003**
  Model 2[†](#TFN5){ref-type="table-fn"}    317       8.4(0.2)             7.8(0.3)     0.034       63   8.0(0.4)                                        6.6(0.4)      **0.004**
  Model 3[‡](#TFN6){ref-type="table-fn"}    287       8.5(0.2)             8.1(0.3)     0.085       58   8.0(0.4)                                        6.8(0.4)      **0.015**
                                                                                                                                                                       
  HbA1c (mmol/mol)                                                                                                                                                     
  Model 1[\*](#TFN4){ref-type="table-fn"}   343       68.5(2.4)            62.0(3.0)    0.037       67   65.2(4.0)                                       50.5(4.4)     **0.003**
  Model 2[†](#TFN5){ref-type="table-fn"}    317       68.4(2.4)            61.6(3.0)    0.034       63   64.1(4.1)                                       49.1(4.8)     **0.004**
  Model 3[‡](#TFN6){ref-type="table-fn"}    287       69.8(2.3)            64.7(2.8)    0.085       58   63.9(4.2)                                       51.1(4.8)     **0.015**
                                                                                                                                                                       
  SBP (mmHg)                                                                                                                                                           
  Model 1[\*](#TFN4){ref-type="table-fn"}   359       120.3(1.1)           119.6(1.4)   0.585       68   119.6(2.6)                                      115.2(2.9)    0.160
  Model 2[†](#TFN5){ref-type="table-fn"}    331       119.6(1.1)           119.1(1.3)   0.711       64   120.2(2.5)                                      115.2(3.0)    0.108
  Model 3[‡](#TFN6){ref-type="table-fn"}    299       120.0(1.3)           119.8(1.6)   0.923       59   120.1(4.0)                                      115.0(4.1)    0.134
                                                                                                                                                                       
  DBP (mmHg)                                                                                                                                                           
  Model 1[\*](#TFN4){ref-type="table-fn"}   359       73.9(0.9)            71.9(1.1)    0.084       68   72.9(2.8)                                       65.6(3.1)     **0.029**
  Model 2[†](#TFN5){ref-type="table-fn"}    331       74.1(0.9)            71.7(1.2)    0.051       64   73.2(2.7)                                       64.5(3.1)     **0.009**
  Model 3[‡](#TFN6){ref-type="table-fn"}    299       74.9(1.2)            72.3(1.4)    0.043       59   76.9(4.4)                                       67.7(4.5)     **0.014**
                                                                                                                                                                       
  TC (mg/dL)                                                                                                                                                           
  Model 1[\*](#TFN4){ref-type="table-fn"}   307       184.3(4.0)           180.7(4.9)   0.483       63   178.5(10.5)                                     167.4(11.5)   0.357
  Model 2[†](#TFN5){ref-type="table-fn"}    288       184.2(4.2)           180.1(5.1)   0.450       60   177.3(11.7)                                     164.3(14.1)   0.330
  Model 3[‡](#TFN6){ref-type="table-fn"}    260       198.9(7.2)           194.8(8.0)   0.466       55   199.3(17.9)                                     184.2(18.9)   0.271
                                                                                                                                                                       
  HDL (mg/dL)                                                                                                                                                          
  Model 1[\*](#TFN4){ref-type="table-fn"}   307       40.4(0.9)            41.0(1.2)    0.613       63   35.9(2.0)                                       38.3(2.2)     0.288
  Model 2[†](#TFN5){ref-type="table-fn"}    288       40.3(0.9)            40.9(1.1)    0.662       60   36.0(1.9)                                       39.3(2.2)     0.118
  Model 3[‡](#TFN6){ref-type="table-fn"}    260       39.8(1.6)            40.9(1.8)    0.409       55   35.8(3.3)                                       39.0(3.5)     0.200
                                                                                                                                                                       
  LDL (mg/dL)                                                                                                                                                          
  Model 1[\*](#TFN4){ref-type="table-fn"}   307       110.5(3.2)           108.1(3.9)   0.556       63   109.2(7.7)                                      100.5(8.4)    0.323
  Model 2[†](#TFN5){ref-type="table-fn"}    288       110.2(3.3)           108.5(4.0)   0.693       60   108.0(8.5)                                      98.4(10.3)    0.323
  Model 3[‡](#TFN6){ref-type="table-fn"}    260       120.9(5.8)           119.9(6.4)   0.824       55   128.6(12.4)                                     113.6(13.0)   0.118
                                                                                                                                                                       
  lnTG                                                                                                                                                                 
  Model 1[\*](#TFN4){ref-type="table-fn"}   307       5.0(0.1)             4.9(0.1)     0.099       63   5.2(0.2)                                        4.7(0.2)      **0.011**
  Model 2[†](#TFN5){ref-type="table-fn"}    288       5.0(0.1)             4.9(0.1)     0.063       60   5.2(0.2)                                        4.6(0.2)      **0.004**
  Model 3[‡](#TFN6){ref-type="table-fn"}    260       5.2(0.1)             5.0(0.1)     0.018       55   5.3(0.3)                                        4.7(0.3)      **0.008**
                                                                                                                                                                       
  ApoB (mg/dL)                                                                                                                                                         
  Model 1[\*](#TFN4){ref-type="table-fn"}   224       98.9(3.2)            93.0(3.9)    0.178       47   102.3(9.5)                                      88.8(9.5)     0.244
  Model 2[†](#TFN5){ref-type="table-fn"}    207       98.9(3.2)            92.0(4.0)    0.123       45   103.7(10.2)                                     85.9(11.1)    0.191
  Model 3[‡](#TFN6){ref-type="table-fn"}    192       108.6(5.3)           101.3(5.9)   0.119       42   149.0(20.1)                                     127.8(19.1)   0.089
                                                                                                                                                                       
  \% Elevated ACR                                     OR(95% CI)                                         OR(95% CI)                                                    
  Model 1[\*](#TFN4){ref-type="table-fn"}   295       2.3(1.2, 4.5)        reference    **0.018**   60   7.4(0.8, 67.6)[§](#TFN7){ref-type="table-fn"}   reference     0.075
  Model 2[†](#TFN5){ref-type="table-fn"}    276       2.4(1.2, 4.9)        reference    **0.017**   58   7.4(0.7, 79.0)[§](#TFN7){ref-type="table-fn"}   reference     0.099
  Model 3[‡](#TFN6){ref-type="table-fn"}    251       2.3(1.1, 5.0)        reference    **0.033**   54   10.9(0.5, 233.0)                                reference     0.126

Model 1 adjusts for gender, race or ethnicity (overall only), clinic, highest parental education, smoking status, and activity level

Model 2 includes all variables in Model 1, and additionally adjusts for BMI z-score, and waist z-score

Model 3 includes all variables in Model 2, and additionally adjusts for: time since diagnosis, age at diagnosis, and insulin use, plus anti-hypertensive medication use (SBP, DBP, and ACR outcomes only), and lipid-lowering medication use (lipid outcomes only)

Hosmer and Lemeshow Goodness-of-Fit test shows significant lack-of-fit
